反応 #2290159
ord-245ed905a39c42f09cd6f4a74b39a139
反応方程式
反応物
試薬
反応条件
後処理
- 1温度the mixture was heated at the same temperature for 2 h
- 2抽出extracted with EtOAc
- 3洗浄The extract was washed with brine
- 4乾燥dried over MgSO4
- 5濃縮concentrated
- 6その他purified by NH silica gel column chromatography (hexane/EtOAc)
- 7その他The resulting solid was purified by preparative HPLC (C18, mobile phase: H2O/CH3CN (0.1% TFA included))
- 8抽出extracted with EtOAc
- 9その他The organic layer was separated
- 10乾燥dried over MgSO4
- 11濃縮concentrated in vacuo
実験手順
To a solution of 1-(2-cyclopropyl-3-methylimidazo[1,2-a]pyridin-6-yl)-4-hydroxypyridin-2(1H)-one (100 mg), (5-(trifluoromethyl)thiophen-2-yl)methanol (130 mg) and tributylphosphine (0.27 ml) in THF (10 ml) was added 1,1′-(azodicarbonyl)dipiperidine (269 mg) at 60° C., and the mixture was heated at the same temperature for 2 h. The mixture was poured into water, and extracted with EtOAc. The extract was washed with brine, dried over MgSO4, concentrated, and purified by NH silica gel column chromatography (hexane/EtOAc), followed by silica gel column chromatography (EtOAc/MeOH). The resulting solid was purified by preparative HPLC (C18, mobile phase: H2O/CH3CN (0.1% TFA included)). The desired fraction was neutralized with saturated NaHCO3 solution, and extracted with EtOAc. The organic layer was separated, dried over MgSO4 and concentrated in vacuo to give the title compound (32.0 mg) as a white solid.